Literature DB >> 23688094

HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.

Don C Des Jarlais1, Dennis McCarty, William A Vega, Heidi Bramson.   

Abstract

Racial/ethnic disparities in HIV infection, with minority groups typically having higher rates of infection, are a formidable public health challenge. In the United States, among both men and women who inject drugs, HIV infection rates are elevated among Hispanics and non-Hispanic Blacks. A meta-analysis of international research concluded that among persons who inject drugs, racial and ethnic minorities were twice as likely to acquire an HIV infection, though there was great variation across the individual studies. To examine strategies to reduce racial/ethnic disparities among persons who inject drugs, we reviewed studies on injection drug use and its role in HIV transmission. We identified four sets of evidence-based interventions that may reduce racial/ethnic disparities among persons who inject drugs: HIV counseling and testing, risk reduction services, access to antiretroviral therapy, and drug abuse treatment. Implementation of these services, however, is insufficient in many countries, including the United States. Persons who inject drugs appear to be changing drug use norms and rituals to reduce their risks. The challenges are to (a) develop a validated model of how racial/ethnic disparities in HIV infection arise, persist, and are reduced or eliminated over time and (b) implement evidence-based services on a sufficient scale to eliminate HIV transmission among all persons who inject drugs.

Entities:  

Mesh:

Year:  2013        PMID: 23688094      PMCID: PMC3710402          DOI: 10.1037/a0032745

Source DB:  PubMed          Journal:  Am Psychol        ISSN: 0003-066X


  83 in total

1.  HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemic.

Authors:  D C Des Jarlais; M Marmor; P Friedmann; S Titus; E Aviles; S Deren; L Torian; D Glebatis; C Murrill; E Monterroso; S R Friedman
Journal:  Am J Public Health       Date:  2000-03       Impact factor: 9.308

2.  Behavioral risk reduction in a declining HIV epidemic: injection drug users in New York City, 1990-1997.

Authors:  C Des Jarlais; T Perlis; S R Friedman; T Chapman; J Kwok; R Rockwell; D Paone; J Milliken; E Monterroso
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

3.  Overland heroin trafficking routes and HIV-1 spread in south and south-east Asia.

Authors:  C Beyrer; M H Razak; K Lisam; J Chen; W Lui; X F Yu
Journal:  AIDS       Date:  2000-01-07       Impact factor: 4.177

4.  A tale of two futures: HIV and antiretroviral therapy in San Francisco.

Authors:  S M Blower; H B Gershengorn; R M Grant
Journal:  Science       Date:  2000-01-28       Impact factor: 47.728

5.  Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization.

Authors:  W E Cunningham; L E Markson; R M Andersen; S H Crystal; J A Fleishman; C Golin; A Gifford; H H Liu; T T Nakazono; S Morton; S A Bozzette; M F Shapiro; N S Wenger
Journal:  J Acquir Immune Defic Syndr       Date:  2000-10-01       Impact factor: 3.731

6.  Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives.

Authors:  J H Samet; P Friedmann; R Saitz
Journal:  Arch Intern Med       Date:  2001-01-08

7.  Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users.

Authors:  D D Celentano; N Galai; A K Sethi; N G Shah; S A Strathdee; D Vlahov; J E Gallant
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

8.  Feasibility, safety, and efficacy of injectable heroin prescription for refractory opioid addicts: a follow-up study.

Authors:  J Rehm; P Gschwend; T Steffen; F Gutzwiller; A Dobler-Mikola; A Uchtenhagen
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

Review 9.  Heroin-assisted treatment as a response to the public health problem of opiate dependence.

Authors:  Benedikt Fischer; Jürgen Rehm; Maritt Kirst; Miguel Casas; Wayne Hall; Michael Krausz; Nicky Metrebian; Jean Reggers; Ambros Uchtenhagen; Wim van den Brink; Jan M van Ree
Journal:  Eur J Public Health       Date:  2002-09       Impact factor: 3.367

10.  Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users.

Authors:  Evan Wood; Thomas Kerr; Elisa Lloyd-Smith; Chris Buchner; David C Marsh; Julio Sg Montaner; Mark W Tyndall
Journal:  Harm Reduct J       Date:  2004-11-09
View more
  10 in total

1.  The Contribution of Missed Clinic Visits to Disparities in HIV Viral Load Outcomes.

Authors:  Anne Zinski; Andrew O Westfall; Lytt I Gardner; Thomas P Giordano; Tracey E Wilson; Mari-Lynn Drainoni; Jeanne C Keruly; Allan E Rodriguez; Faye Malitz; D Scott Batey; Michael J Mugavero
Journal:  Am J Public Health       Date:  2015-08-13       Impact factor: 9.308

2.  Continued Transmission of HIV Among Young Adults Who Inject Drugs in San Francisco: Still Room for Improvement.

Authors:  Ali Mirzazadeh; Jennifer L Evans; Judith A Hahn; Jennifer Jain; Alya Briceno; Stephen Shiboski; Paula J Lum; Christopher Bentsen; Geoff Davis; Kathy Shriver; Melanie Dimapasoc; Mars Stone; Michael P Busch; Kimberly Page
Journal:  AIDS Behav       Date:  2018-04

3.  Exchange Sex and HIV Infection Among Women Who Inject Drugs-20 US Cities, 2009.

Authors:  Lina M Nerlander; Kristen L Hess; Charles E Rose; Catlainn Sionean; Anna Thorson; Dita Broz; Gabriela Paz-Bailey
Journal:  J Acquir Immune Defic Syndr       Date:  2017-07-01       Impact factor: 3.731

4.  How are transgender women acquiring HIV? Insights from phylogenetic transmission clusters in San Francisco.

Authors:  Hong-Ha M Truong; Kara J O'Keefe; Sharon Pipkin; Teri Liegler; Susan Scheer; Erin Wilson; Willi McFarland
Journal:  AIDS       Date:  2019-11-01       Impact factor: 4.177

5.  A Randomized Trial to Evaluate the Efficacy of a Web-Based HIV Behavioral Intervention for High-Risk African American Women.

Authors:  Douglas W Billings; Samantha L Leaf; Joy Spencer; Terrlynn Crenshaw; Sheila Brockington; Reeshad S Dalal
Journal:  AIDS Behav       Date:  2015-07

6.  Impaired verbal memory in individuals living with HIV and cocaine dependence.

Authors:  Sarah E Nigro; Minjie Wu; Anthony C Juliano; T Celeste Napier; Alan L Landay; Audrey L French; Shaolin Yang
Journal:  J Clin Exp Neuropsychol       Date:  2022-07-04       Impact factor: 2.283

Review 7.  Reducing HIV Risk Behaviors Among Black Women Living With and Without HIV/AIDS in the U.S.: A Systematic Review.

Authors:  Amber I Sophus; Jason W Mitchell
Journal:  AIDS Behav       Date:  2020-09-12

8.  Prevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009.

Authors:  Dita Broz; Huong Pham; Michael Spiller; Cyprian Wejnert; Binh Le; Alan Neaigus; Gabriela Paz-Bailey
Journal:  AIDS Behav       Date:  2014-04

9.  Trajectories of Aging Long-Term Mexican American Heroin Injectors: The "Maturing Out" Paradox.

Authors:  Alice Cepeda; Kathryn M Nowotny; Avelardo Valdez
Journal:  J Aging Health       Date:  2015-05-07

10.  Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.

Authors:  Suzan M Walters; Kathleen H Reilly; Alan Neaigus; Sarah Braunstein
Journal:  Harm Reduct J       Date:  2017-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.